GHRP-6 Dosage Guide
Written by Alejandro Reyes
Founder & Lead Researcher
Reviewed by Peptide Nerds Editorial · Updated April 2026
Dosage overview
| Typical dose | 100-300 mcg per injection |
| Frequency | 2-3 times daily on an empty stomach |
| Cycle length | 8-12 weeks, followed by a 4-week break |
Dosing notes
Inject subcutaneously, typically into the abdomen, at least 2 hours after the previous meal. Wait 20 to 30 minutes after injection before eating to avoid insulin-mediated blunting of the GH response. The intense hunger that follows within 15 to 20 minutes of injection makes pre-meal timing essential for practical compliance. Users who inject in a fasted state and then eat a high-protein meal capitalize on the anabolic window created by simultaneous GH elevation and nutrient availability. The most common timing windows are morning (fasted upon waking), pre-workout (45 to 60 minutes before training), and pre-sleep (2 hours after last meal). Stacking with a GHRH analog such as CJC-1295 or modified GRF(1-29) substantially amplifies GH output and is standard practice in research protocols. Users who find GHRP-6's appetite effect unmanageable should consider GHRP-2, which produces similar GH stimulation with notably less appetite stimulation, or ipamorelin, which is the most selective GHRP with minimal appetite and cortisol effects.
Important safety information
Dosage ranges listed above are based on available research data and reported protocols. Individual dosing should be determined by a qualified healthcare provider based on your specific health profile, goals, and response to treatment.
- Start at the lowest effective dose and titrate up gradually
- Monitor for side effects, especially during dose increases
- Do not exceed researched dose ranges without medical supervision
- This is a research compound — human dosing guidelines are not FDA-established
Research references
- Comparison of growth hormone (GH)-releasing peptides: stimulation of GH release from perifused rat anterior pituitaries by GHRP-1, GHRP-2, GHRP-6, hexarelin, and MK-0677 — Endocrinology (1997) [PubMed]
- Growth hormone-releasing activity of a synthetic hexapeptide in normal volunteers and subjects with short stature — Journal of Clinical Endocrinology and Metabolism (1993) [PubMed]
- GHRP-6 increases food intake in healthy subjects and patients with anorexia nervosa — Clinical Endocrinology (1994) [PubMed]
Free Peptide Weight Loss Guide
Semaglutide vs. tirzepatide vs. retatrutide. Dosing protocols, side effects, gray market sourcing, and what the clinical trials found.